Business Wire

O-RAN-ALLIANCE

Share
O-RAN ALLIANCE Announces Speakers at the Open RAN Summit at Fyuz and Changes in its Leadership

O-RAN ALLIANCE:

Upcoming Open RAN Summit @ Fyuz features O-RAN leadership

The Open RAN Summit @ Fyuz, powered by the O-RAN ALLIANCE and Telecom Infra Project, will take place in Madrid on October 25-26, 2022, where leaders of open, disaggregated and intelligent network solutions and the broader telecoms industry will gather to share experiences and discuss paths to success. Registration has been open at www.fyuz.events with early bird discounts available until August 30, 2022.

Speakers featuring O-RAN leadership include:

  • Alex Jinsung Choi, Chief Operating Officer of the O-RAN ALLIANCE and SVP of Strategy and Technology Innovation, Deutsche Telekom
  • Chih-Lin I, Co-chair of O-RAN Technical Steering Committee and Chief Scientist, China Mobile
  • Claire Chauvin, Strategy Architecture and Standardization Director, Orange
  • Sadayuki Abeta, VP and General Manager of Radio Access Network Development Department, NTT DOCOMO

See up-to-date information and speaker lineup at the event website www.fyuz.events.

Andre Fuetsch retires from AT&T and his chairmanship of the O-RAN Board

Andre Fuetsch, chairman of the O-RAN Board and Network Chief Technology Officer of AT&T, has announced his retirement from AT&T effective August 30, 2022, and will also step down from his Chairman position at the O-RAN ALLIANCE on the same date. AT&T will remain on the O-RAN Board as a founding member.

“Under Andre’s leadership, O-RAN has grown to a well-respected body changing the paradigm of Radio Access Networks towards openness, intelligence and innovation,” said Alex Jinsung Choi, Chief Operating Officer and interim Chairman of the O-RAN ALLIANCE and SVP of Strategy and Technology Innovation at Deutsche Telekom. “Many thanks to Andre for his chairmanship in the past four years and lots of success in his next career and personal life.”

O-RAN ALLIANCE Work Groups and Focus Groups to rejoin in-person

O-RAN ALLIANCE plans to resume regular face-to-face meetings of its Work Groups and Focus Groups, with the next one to take place in October 2022 in Madrid. Companies and institutions with O-RAN membership will meet in-person to intensify the progress of O-RAN specification effort. The meeting is being prepared with full respect of current health and travel regulations and will allow remote participation of delegates unable to travel.

About O-RAN ALLIANCE

The O-RAN ALLIANCE is a world-wide community of more than 320 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.

For more information, please visit www.o-ran.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220826005145/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mandate of BaFin’s special commissioner at flatexDEGIRO terminated18.10.2024 17:25:00 CEST | Press release

Mandate of BaFin’s special commissioner at flatexDEGIRO terminated The mandate of the BaFin’s special commissioner at flatexDEGIRO Bank AG (the “Company”) was terminated on September 30, 2024, following the successful elimination of the serious deficiencies identified in the 2022 special audit by the Company and a positive review by the special commissioner. flatexDEGIRO AG made this announcement on October 18, 2024, following a corresponding decision by the German Federal Financial Supervisory Authority (BaFin). Oliver Behrens, CEO of flatexDEGIRO, said: “We have realigned and sustainably strengthened our organizational structures and processes in constructive cooperation with BaFin and the special commissioner. We are thereby closing a regulatory chapter and again increase our focus on our customers and important growth projects. My special thanks go to all employees who, under the leadership of Steffen Jentsch, member of the bank's management board, have made it possible to reach th

Biological Lattice Industries (BLI) Secures $1.8 Million Pre-Seed Funding Led by Uni.Fund to Democratize Biofabrication18.10.2024 16:00:00 CEST | Press release

Biological Lattice Industries Corp. (BLI), a leading innovator in biofabrication and life sciences R&D, today announced the successful closing of a $1.8 million pre-seed investment round led by Greek venture capital firm Uni.Fund. In conjunction with this funding announcement , BLI is introducing its first all-in-one solution for biofabrication: BioLoom™, BLI's advanced multi-tool 3D bioprinter and Loominus Studio™, its unified software platform designed to revolutionize biofabrication workflows. BLI, a US startup with R&D operations in Greece, aims to radically simplify biofabrication for the global R&D community by providing intelligent, automated tools that streamline the design, fabrication, and testing of biomaterials. Biomaterials are critical for a wide array of biological applications. The applications range from advanced 3D cell culture systems for human biology emulation to the next-generation of resorbable medical devices and drug delivery systems for tissue trauma repair. “

Gurobi Brings Decision Intelligence Summit to Amsterdam18.10.2024 15:00:00 CEST | Press release

The event will unite industry leaders from across the EMEAI region for two days of in-person learning and networking. Gurobi Optimization, LLC, the leader in decision intelligence technology, is set to host the first annual EMEAI Decision Intelligence Summit (“Gurobi Summit”) at Amsterdam’s Capital C on November 5-6, 2024. Following the success of last month’s inaugural summit for the Americas in Las Vegas, the EMEAI Summit will bring together operations researchers, data scientists, and business leaders from across the region to explore the latest advancements in mathematical optimization and decision intelligence. The Gurobi Summit will feature special presentations from companies such as Accenture and ICRON. Several of the company’s partners—including Decide4AI, Decision Labs, LTPLabs, and ORMAE—will also be present to showcase their solutions and insights. The two-day event will be packed with informative presentations, exciting customer case studies, and interactive learning oppor

Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting18.10.2024 14:00:00 CEST | Press release

-- Phase 3 abstract selected for presentation in “Best Abstract” session -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor for the treatment of moderate-to-severe acute pain, at the annual meeting of the American Society of Anesthesiologists (ASA), taking place from October 18-22, 2024 in Philadelphia, Pennsylvania. Abstract A1187 — “Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After Abdominoplasty or Bunionectomy” will be presented as an oral presentation on Sunday, October 20, during the “Best Abstract” session, which runs from 8:00-11:00 a.m. ET, as well as the Education session which runs on Monday, October 21, from 1:30-2:30 p.m. ET. Abstract A2074 — “A Phase 3, Single-Arm Study of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor For Treatm

MDPI Champions Open Access for Global Progress18.10.2024 10:00:00 CEST | Press release

During International Open Access Week 2024, MPDI promotes open scholarship to accelerate scientific discovery and advance social outcomes MDPI, a leading open access (OA) publisher, is proud to announce its participation in International Open Access Week 2024, 21–27 October. This year’s theme, “Community over Commercialization”, resonates with MDPI’s commitment to publishing insights for everyone, regardless of background. OA Week is a valuable opportunity to inspire engagement with the open access movement and to advocate for more sustainable and inclusive scholarly communication. This mission, shared by MDPI, helps to ensure that all communities have the means to participate in shaping global futures. To support these aims, MDPI will be sharing a variety of digital resources discussing quality and ethics in OA publishing, the tools we provide to support researchers, and the benefits of OA and open research. For more information on MDPI’s initiatives, please visit our website. By work

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye